πŸ‡ΊπŸ‡Έ FDA
Patent

US 8637568

Serotonin reuptake inhibitors

granted A61KA61K31/40A61K31/41

Quick answer

US patent 8637568 (Serotonin reuptake inhibitors) held by Theravance, Inc. expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/40, A61K31/41, A61K31/4155, A61K31/4178